Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "Template:Current week ecosystem agenda"

From Bioblast
Line 1: Line 1:
{{Template:Science for Ukraine}}
{{Template:Science for Ukraine}}
  2022 Week 35
  2022 Week 36


*'''Aug-29 Mo'''
*'''Sep-05 Mo''' - Prostate Cancer Awareness Month
:{|
:{|
| width="100" align="center" |[[File:NextGenO2k logo.jpg|right|80px|link=https://www.oroboros.at/index.php/product/nextgen-o2k_photobiology/|NextGen-O2k PhotoBiology]]
| width="100" align="center" |[[Image:O2k-Publications.jpg|70px|link=http://wiki.oroboros.at/index.php/O2k-Publications:_Topics |O2k-Publications in the MiPMap]]
 
|'''“Mitochondria of the malignant prostate cells have a higher affinity for succinate and this metabolite supports mitochondrial physiology through the induction of expression and activities of mitochondrial complexes”'''<br>
*Bastos Sant'Anna Silva AC, Perez-Valencia JA, Sciacovelli M, Lalou C, Sarlak S, Tronci L, Nikitopoulou E, Meszaros AT, Frezza C, Rossignol R, Gnaiger E, Klocker H (2021) Succinate anaplerosis has an onco-driving potential in prostate cancer cells. Cancers 13:1727.[[Bastos Sant'Anna Silva 2021 Cancers|»Bioblast link«]]
 
:from the O2k-Network »[[AT Innsbruck Oroboros]]« and »[[FR Bordeaux Rossignol R]]«


|'''An article and video about the NextGen-O2k PhotoBiology Module, which was nominated for the Tyrolean Innovation Prize, were recently published (in German).''' <br>
- » [https://www.wko.at/site/tiroler-innovationspreis/oroboros.html Read and watch here] «
|}
|}
----
----


*'''Aug-30 Tu'''
*'''Sep-06 Tu'''
:{|
:{|
| width="110" align="center" | [[Image:O2k-Support.jpg|60px|link=http://wiki.oroboros.at/index.php/O2k-Open_Support |O2k-Open Support]][[File:Blue-info.png|25px|Info: improve]]
 
|'''Keep it running or switch it off – what is best for your O2k?'''<br>
| width="110" align="center" | [[Image:Quality management.png|left|60px|link=http://wiki.oroboros.at/index.php/MitoPedia:_Oroboros_QM |Oroboros quality management]]
Switching off the O2k after use increases the lifespan of the OroboPOS and saves energy <br>
 
- »[[MiPNet22.11_O2k-FluoRespirometer_manual]]« and »[[MiPNet19.03_O2k-cleaning_and_ISS]]« <br>
|'''How does proficiency testing help achieve quality and reproducibility? '''<br>
- communicated by »[[Schmitt Sabine]]« and »[[Tindle-Solomon Lisa]]«
Providing a pre-established set of testing criteria improves and standardizes technical performance. <br>
 
- »'''[[Proficiency test]]'''«<br>
 
- communicated by »[[Baglivo Eleonora]]« and »[[Tindle-Solomon Lisa]]«
 
|}
|}
----
----


*'''Aug-31 We'''
*'''Sep-07 We'''


----
----


*'''Sep- 01 Th''' - Leukemia and Lymphoma Awareness Month
*'''Sep-08 Th'''
:{|
| width="100" align="center" |[[Image:O2k-Publications.jpg|70px|link=http://wiki.oroboros.at/index.php/O2k-Publications:_Topics |O2k-Publications in the MiPMap]]
|'''Metformin-mediated reduction of mitochondrial activity contributes to decreased cell viability in myeloproliferative neoplasms cells'''<br>
*Machado-Neto JA, Fenerich BA, Scopim-Ribeiro R, Eide CA, Coelho-Silva JL, Dechandt CRP, Fernandes JC, Rodrigues Alves APN, Scheucher PS, Simões BP, Alberici LC, de Figueiredo Pontes LL, Tognon CE, Druker BJ, Rego EM, Traina F (2018) Metformin exerts multitarget antileukemia activity in JAK2V617F-positive myeloproliferative neoplasms. Cell Death Dis 9:311. [[Machado-Neto 2018 Cell Death Dis|»Bioblast link«]]
 
:from the O2k-Network »[[BR Ribeirao Preto Alberici LC]]«
 
|}


----
----


*'''Sep-02 Fr'''
*'''Sep-09 Fr'''

Revision as of 08:43, 5 September 2022

Gentle Science
Oroboros declares solidarity against the Russian aggression-war in Ukraine and against all aggression-wars worldwide. -  »More details
A future for Ukraine is the future of its science
2022 Week 36
  • Sep-05 Mo - Prostate Cancer Awareness Month
O2k-Publications in the MiPMap “Mitochondria of the malignant prostate cells have a higher affinity for succinate and this metabolite supports mitochondrial physiology through the induction of expression and activities of mitochondrial complexes”
  • Bastos Sant'Anna Silva AC, Perez-Valencia JA, Sciacovelli M, Lalou C, Sarlak S, Tronci L, Nikitopoulou E, Meszaros AT, Frezza C, Rossignol R, Gnaiger E, Klocker H (2021) Succinate anaplerosis has an onco-driving potential in prostate cancer cells. Cancers 13:1727.»Bioblast link«
from the O2k-Network »AT Innsbruck Oroboros« and »FR Bordeaux Rossignol R«

  • Sep-06 Tu
Oroboros quality management
How does proficiency testing help achieve quality and reproducibility?

Providing a pre-established set of testing criteria improves and standardizes technical performance.

- »Proficiency test«

- communicated by »Baglivo Eleonora« and »Tindle-Solomon Lisa«


  • Sep-07 We

  • Sep-08 Th

  • Sep-09 Fr